Philadelphia Business Journal January 3, 2013 Discovery Labs launches Afectair, Surfaxin in the wings
Philadelphia Business Journal January 3, 2012 Discovery Labs extends lease at Warrington HQ
Philadelphia Business Journal October 5, 2012 Discovery Labs Named Life Sciences Company of the Year
NEONATOLOGY TODAY July 2012 Issue Table of Contents, Volume 7 / Issue 7 http://www.neonatologytoday.net/newsletters/nt-jul12.pdf
Jun 11, 2013 Discovery Labs Presents Final Assessment in a Series of Pharmacoeconomic Analyses that Explore Impact of Reintubation on Healthcare Costs
Jun 10, 2013 Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN® (lucinactant) Updated Product Specifications
May 15, 2013 Discovery Labs Announces Completion of $14.25 Million Public Offering
May 10, 2013 Discovery Labs Prices $14.25 Million Public Offering of Common Stock
May 9, 2013 Discovery Labs Announces Proposed Public Offering of Common Stock
